Cart
sales@molnova.com
Antitubercular agent-41
CAS No. 901032-23-3
Antitubercular agent-41( —— )
Catalog No. M35315 CAS No. 901032-23-3
Antitubercular agent-41 is a antibacterial agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 153 | In Stock |
|
| 10MG | 225 | In Stock |
|
| 25MG | 337 | In Stock |
|
| 50MG | 465 | In Stock |
|
| 100MG | 625 | In Stock |
|
| 200MG | 828 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAntitubercular agent-41
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntitubercular agent-41 is a antibacterial agent.
-
DescriptionAntitubercular agent-41 (Compound 106) is an antitubercular agent that can be used in the study of Mycobacterium tuberculosis infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorAntibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number901032-23-3
-
Formula Weight405.42
-
Molecular FormulaC23H20FN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C1=CC=2C(=NC=3C(C2)=CC(OC)=CC3)O1)N4CCN(CC4)C5=CC=C(F)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Александр Васильевич Иващенко, et al. FURO- AND THIENO[2,3-b]-QUINOLINE-2-CARBOXAMIDES, METHOD OF PRODUCTION AND ANTITUBERCULOUS ACTIVITY. Patent RU2371444C1.
molnova catalog
related products
-
Cefepime
Cefepime (BMY-28142) is a cephalosporin antibiotic with antimicrobial activity, induces neurotoxicity, inhibits both Gram-positive and Gram-negative, and can be used in the study of anaerobic bacteria.
-
Olivetolic acid
Olivetolic acid (OLA) is a precursor of cannabinoids from Cannabis sativa and has shown anticonvulsant activity in a mouse model of Dravet syndrome.
-
Golotimod
Golotimod (SCV 07) is an antimicrobial dipeptide with immunomodulatory activity that significantly improves the efficacy of anti-tuberculosis therapy.
